OverviewSuggest Edit

BioCorRx Inc. operates alcoholism rehabilitation and treatment centers in California. The company distributes and licenses BioCorRx Recovery Program for the treatment of alcoholism and opioid addiction consisting of a Naltrexone implant that is placed under the skin in the lower abdomen coupled with a counseling/life coaching program, including sessions from specialized life coaches and/or counselors. Its program is primarily used by independently owned and licensed clinics.
TypePublic
Founded2008
HQSanta Ana, US
Websitebiocorrx.com

Latest Updates

Employees (est.) (Sep 2017)5
Revenue (FY, 2018)$376.7 K(-42%)

BioCorRx Office Locations

BioCorRx has an office in Santa Ana
Santa Ana, US (HQ)
Santa Ana, CA 92705, USA
Show all (1)

BioCorRx Financials and Metrics

BioCorRx Revenue

BioCorRx's revenue was reported to be $376.66 k in FY, 2018
USD

Revenue (FY, 2018)

376.7k

Net income (FY, 2018)

(6.6m)

EBIT (FY, 2018)

(4.6m)

Market capitalization (8-Oct-2018)

24.5m

Cash (31-Dec-2018)

279.8k
BioCorRx's current market capitalization is $24.5 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

715.0k924.7k701.8k657.3k376.7k

Cost of goods sold

160.2k

Gross profit

554.8k

Gross profit Margin, %

78%
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q3, 2016Q1, 2018Q2, 2018

Revenue

130.8k238.0k434.0k457.8k118.2k167.6k147.7k246.4k

Cost of goods sold

27.7k47.3k84.4k

Gross profit

103.1k190.7k349.7k

Gross profit Margin, %

79%80%81%
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

108.6k220.1k92.5k11.3k279.8k

Accounts Receivable

299.2k2.8k30.0k8.0k

Current Assets

529.1k312.1k100.9k54.5k319.2k

PP&E

8.8k3.9k22.2k19.0k44.4k
Quarterly
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(3.8m)(4.7m)(5.9m)(29.7m)(6.6m)

Depreciation and Amortization

135.5k125.1k30.2k33.9k7.4k

Accounts Payable

505.6k480.7k(42.7k)548.2k385.6k

Cash From Operating Activities

103.5k47.9k(2.0m)(2.5m)(1.8m)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q3, 2016Q1, 2018Q2, 2018

Net Income

(1.1m)(736.6k)(1.1m)(4.7m)(4.2m)(1.0m)(2.2m)

Depreciation and Amortization

34.0k67.9k101.8k67.3k96.2k21.7k3.4k4.7k

Accounts Payable

62.5k(76.4k)59.4k201.9k389.6k(371.6k)96.4k25.7k

Cash From Operating Activities

144.0387.4k101.9k(394.8k)(504.5k)(1.6m)(409.5k)(954.8k)
Show all financial metrics

BioCorRx Online and Social Media Presence

Embed Graph

BioCorRx News and Updates

BioCorRx, Inc. Announces Launch of Pilot Program with Louisiana Department of Corrections for Offenders Suffering with Alcohol and Opioid Use Disorders

Anaheim, CA - (NewMediaWire) - May 02, 2019 - BioCorRx Inc. (OTCQB: BICX) (“BioCorRx®”)(“Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announces treatment of the first patient in its partnership with the Louisiana De…

BioCorRx Inc. Unveils New UnCraveRx Weight Loss Program; Appoints Notable Dr. Kenneth Orbeck as Medical Director

Anaheim, CA - (NewMediaWire) - May 01, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that it has unveiled its new UnCraveRx™ Weight Loss Program and appointed Dr. Ke…

BioCorRx to Present at the Planet MicroCap Showcase 2019 on May 1st in Las Vegas

ANAHEIM, CA, April 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced it will present at the Planet MicroCap Showcase at 4:00 p.m. …

Joseph J. Galligan Appointed as Senior Advisor to BioCorRx Inc.

ANAHEIM, CA - (NewMediaWire) - April 04, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced that Joseph J. Galligan has been appointed as senior advisor to the Company.Mr…

BioCorRx Announces Above Market $6 Million Private Placement at $15 Per Share

ANAHEIM, CA - (NewMediaWire) - April 02, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company”), a leader, developer and provider of advanced solutions in the treatment of addiction and related disorders, today announced the Company completed a private placement, whereby it issued 400,000 common st…

BioCorRx's Subsidiary, BioCorRx Pharmaceuticals, to Exhibit at ASAM 50th Annual Conference in Orlando, Florida

ANAHEIM, CA - (NewMediaWire) - March 28, 2019 - BioCorRx Inc. (OTCQB: BICX) (the “Company), a developer and provider of advanced solutions in the treatment of substance abuse disorders, today announced that the Company’s subsidiary, BioCorRx Pharmaceuticals, will exhibit at the American Society…
Show more

BioCorRx Frequently Asked Questions

  • When was BioCorRx founded?

    BioCorRx was founded in 2008.

  • How many employees does BioCorRx have?

    BioCorRx has 5 employees.

  • What is BioCorRx revenue?

    Latest BioCorRx annual revenue is $376.7 k.

  • What is BioCorRx revenue per employee?

    Latest BioCorRx revenue per employee is $75.3 k.

  • Who are BioCorRx competitors?

    Competitors of BioCorRx include STEAM France, Molina Healthcare and Conmed.

  • Where is BioCorRx headquarters?

    BioCorRx headquarters is located at Santa Ana, CA 92705, USA, Santa Ana.

  • Where are BioCorRx offices?

    BioCorRx has an office in Santa Ana.

  • How many offices does BioCorRx have?

    BioCorRx has 1 office.